3-[(5-Chloro-2-hydroxyphenyl) methyl]-5-[4-(trifluoromethyl) phenyl]-1, 3, 4-oxadiazol-2 (3 H)-one, BMS-191011: Opener of Large-Conductance Ca2+-Activated …
JL Romine, SW Martin, NA Meanwell…
Index: Journal of Medicinal Chemistry, , vol. 50, # 3 p. 528 - 542
Full Text: HTML
Citation Number: 31
Abstract
... Journal of Medicinal Chemistry. ... Bristol-Myers Squibb Pharmaceutical Research Institute, 5 Research Parkway, Wallingford, Connecticut 06492. J. Med. Chem. , 2007, 50 (3), pp 528–542. DOI: 10.1021/jm061006n. Publication ...
Related Articles:
[Grimster, Neil P.; Connelly, Stephen; Baranczak, Aleksandra; Dong, Jiajia; Krasnova, Larissa B.; Sharpless, K. Barry; Powers, Evan T.; Wilson, Ian A.; Kelly, Jeffery W. Journal of the American Chemical Society, 2013 , vol. 135, # 15 p. 5656 - 5668]
[Journal of Heterocyclic Chemistry, , vol. 50, # 4 p. 945 - 948]